Washington, DC 20006-5349
HELPLINE
This week, the Mesothelioma Applied Research Foundation, the leading organization funding mesothelioma research and providing patient services, announced the election of new Co-Chairs of its Board of Directors.
Read more in our press release here http://www.prweb.com/releases/2011/1/prweb8090988.htm.
Mental health is a big issue for mesothelioma patients, caregivers, and family members. This session covers how patients as well as their loved ones can
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
